The world's first AI-generated antibody drug

Chugai Pharmaceutical has started Phase 1 clinical trials for the world's first AI-generated antibody drug. We took a look at the current status of the company's AI drug discovery and the problems it faces.
https://miyata-bio.net/column/0000402/